Newsroom

Sorted by: Latest

-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Max Buffer UCITS ETF- June 16.03.2026 MJUN LN IE000CO3P697 150,002.00 USD 3,728,827.05 24.859  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - December 16.03.2026 QDEC.LN IE000GAKWFA7 450,002.00 USD 10,155,412.63 22.567  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Europe Infrastructure UCITS ETF 16.03.2026 FTEI.LN IE000TIZ5AP4 150,002.00 EUR 3,010,752.76 20.071  ...
-

Universal Fuel Technologies Demonstrates Fully Drop-In Synthetic Aviation Fuel Using HEFA Byproducts

LOS ALTOS, Calif.--(BUSINESS WIRE)--As airlines work to reduce emissions while maintaining operational efficiency with existing aircraft and infrastructure, a critical barrier to 100% sustainable aviation fuel (SAF) adoption has been overcome. Independent testing by Washington State University has validated that Universal Fuel Technologies’ (Unifuel) Flexiforming technology successfully converts HEFA-derived naphtha into synthetic aromatic kerosene that, when blended with paraffinic SAF, create...
-

Doximity Study Finds Physicians Rapidly Adopting AI, But Accuracy Concerns Persist

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today released a new report examining how physicians are adopting artificial intelligence (AI) in clinical practice. The findings show that AI adoption and interest are widespread: 94% of physicians reported they are currently using AI or interested in doing so. At the same time, physicians remain cautious, with 71% citing accuracy and reliability as their top concern. “AI h...
-

Alloy Therapeutics Enters Into Agreement to Advance Novel Antibody Discovery Platform

BOSTON--(BUSINESS WIRE)--Alloy Therapeutics, Inc. (“Alloy”), a biotechnology ecosystem company dedicated to democratizing access to cutting-edge drug discovery technologies, today announced an agreement with AbbVie to develop a new antibody platform to discover potent, specific, and effective antibodies against targets that are difficult to address with current technologies. As part of the multi-year agreement, Alloy will receive an upfront payment, as well as an additional payment in connectio...
-

New Global Study: One in Three Workers is "Merely Surviving" as Mental Health Needs Outpace Traditional Benefits

BURLINGAME, Calif.--(BUSINESS WIRE)--Lyra Health today released its 2026 State of Workforce Mental Health Report, “The Workforce Mental Health Paradox,” revealing a growing disconnect in workplace mental health: while more employees have access to care than ever before, many continue to struggle. The findings highlight a critical reality for employers: expanding access to mental health support is not enough if employees cannot reach the right level of high-quality care when they need it. More t...
-

Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON--(BUSINESS WIRE)--Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today announced that, effective on March 11, 2026, Sensei’s Board of Directors granted a new employee an option to purchase 166,435 shares of the Company’s common stock in connection with their employment (collectively, the “Option Award”). The Option Award was granted as an inducement material to the individual entering employment with Sensei in accordance with Nasdaq Listing Rule 5635(c)(4). The Option Award has an exercise...
-

O2 Investment Partners Announces Appointment of Nick Lemire

BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--O2 Investment Partners announced today the appointment of Nick Lemire as the firm’s newest Associate....
-

Jozu Launches Agent Guard: AI Security That AI Agents Cannot Disable

NEW YORK--(BUSINESS WIRE)--Jozu, the AI assurance company behind KitOps, a CNCF project with more than 240,000 downloads, today announced the launch of Jozu Agent Guard, a zero-trust AI runtime that executes agents, models, and MCP servers inside secured environments with built-in policy enforcement and guardrails that agents cannot disable. Jozu Agent Guard is available today. As enterprises rapidly adopt AI agents, MCP servers, and tools like Copilot, OpenClawd, and Claude Code, security team...